AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

Comments
Loading...
AngioDynamics ANGO today announce the enrollment of the first patient into the Registry of AngioVac Procedures In Detail (RAPID) Database at University of California-Los Angeles (UCLA) Health in Los Angeles, California. The RAPID Database is designed to evaluate the patterns of use as well as safety and effectiveness data of the AngioVac® system in the en bloc removal of fresh, soft thrombi or emboli. According to national principal investigator, Dr. John M. Moriarty, Assistant Professor of Radiology, Director of Cardiology-Interventional Radiology Innovation at UCLA, there has been significant interest in centers wanting to participate in the Registry. "So far, we have centers in 31 states that want to take part in the Registry," said Dr. Moriarty. "Our goal is to include as many potential collaborators as possible, and start gathering much needed data regarding procedural and patient outcomes." Dr. Moriarty added that the registry is also a way to become part of the community of physicians, nurses, and technologists who are working in this field, and connecting with researchers who may not be anywhere near you geographically, See full press release
ANGO Logo
ANGOAngioDynamics Inc
$9.25-2.84%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
95.37
Growth
11.45
Quality
-
Value
64.98
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: